Mika Remes

Cyclin-dependent kinase 5 acts as a critical determinant of AKT-dependent proliferation and regulates differential gene expression by the androgen receptor in prostate cancer cells

Susumu Y. Imanishi, J. Eriksson, J. Palvimo, 2015, Molecular biology of the cell.

The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling.

P. Eklund, J. Eriksson, R. Sjöholm, 2013, Biochemical pharmacology.

Systems analysis of miRNA biomarkers to inform drug safety

J. Dear, F. Falciani, A. Norris, 2021, Archives of Toxicology.